EMPIRICAL VORICONAZOLE vs AMBISOME FOR PERSISTENTLY FEBRILE NEUTROPENICS II Walsh et al, ICAAC Toronto 2000. Abstr L1, Addendum p. 20-21
VORICONAZOLE AMBISOME
Patients
Success
Survival
breakthrough fungus
nephrotoxicity
hepatotoxicity
infusion-related
visual disturbances
415
26%
87%
2%
11%
10%
0%
24%
422
31%
90%
5%
19%
12%
3%
1%
Previous slide
Next slide
Back to first slide
View graphic version